Reduced venetoclax exposure to 7 days vs standard exposure with hypomethylating agents in newly diagnosed AML patients
对于新诊断的急性髓系白血病 (AML) 患者,与使用低甲基化药物的标准疗程相比,将维奈托克暴露时间缩短至 7 天。
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01269-x
Willekens, Christophe; Bazinet, Alexandre; Chraibi, Samy; Bataller, Alex; Decroocq, Justine; Arani, Naszrin; Carpentier, Benjamin; Rausch, Caitlin; Lebon, Delphine; Maiti, Abhishek; Gauthier, Nicolas; Short, Nicholas; Bonnet, Sarah; Sasaki, Koji; Khalife-Hachem, Sabine; Swaminathan, Mahesh; Micol, Jean-Baptiste; Pasquier, Florence; Marzac, Christophe; Roos-Weil, Damien; Pascal, Laurent; Daver, Naval; Kadia, Tapan; Bouscary, Didier; Ravandi, Farhad; Pages, Arnaud; Kantarjian, Hagop; De Botton, Stéphane; DiNardo, Courtney